Pharma Journalist -

Sylentis, Pharmaceutical Company belonging to the PharmaMar Group, has presented results from the clinical studies carried out with tivanisiran for the treatment of dry eye syndrome and…
Read More...

MenoGeniX announced that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant for…
Read More...

Abbott announced U.S. Food and Drug Administration (FDA) clearance of the Advisor HD Grid Mapping Catheter, Sensor Enabled. Advisor HD Grid employs a new design that allows physicians…
Read More...

Ferring Pharmaceuticals announced the signing of an agreement giving the company the option to secure global commercialisation rights to nadofaragene firadenovec/Syn3 (rAd-IFN/Syn3), a…
Read More...

United Therapeutics Corporation and SteadyMed Ltd. announced the signing of a definitive merger agreement under which United Therapeutics will acquire SteadyMed for $4.46 per share in…
Read More...

Innomar Strategies announced the acquisition of regulatory consulting firm Therapeutic Products Inc. (TPIreg). With the addition of TPIreg, Innomar is the first full service distributor…
Read More...

AGC Biologics announced it has entered into an agreement with Horizon Pharma plc for commercial supply of teprotumumab, a monoclonal antibody biologic for the treatment of…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for the adjuvant treatment of patients…
Read More...

AbbVie announced that it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for risankizumab, an investigational interleukin-23 (IL-23)…
Read More...

Bavarian Nordic A/S announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company’s novel cancer vaccine BN-Brachyury for the treatment…
Read More...